Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation
Health Technology Assessment · 2024-08 · 1-228
DOI: 10.3310/vbxx6307 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Health Technology Assessment, 2024-08. Verfasst von Tristan M Snowsill und 9 weiteren Autor:innen. Beteiligte Einrichtung: Health Economics Group, University of Exeter, Exeter, UK. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Cost-Benefit Analysis, Quality-Adjusted Life Years, Genital Neoplasms, Female. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Technology Assessment programme.
Abstract (Originalsprache)
Background
Lynch syndrome is an inherited condition which leads to an increased risk of colorectal, endometrial and ovarian cancer. Risk-reducing surgery is generally recommended to manage the risk of gynaecological cancer once childbearing is completed. The value of gynaecological colonoscopic surveillance as an interim measure or instead of risk-reducing surgery is uncertain. We aimed to determine whether gynaecological surveillance was effective and cost-effective in Lynch syndrome.
Methods
We conducted systematic reviews of the effectiveness and cost-effectiveness of gynaecological cancer surveillance in Lynch syndrome, as well as a systematic review of health utility values relating to cancer and gynaecological risk reduction. Study identification included bibliographic database searching and citation chasing (searches updated 3 August 2021). Screening and assessment of eligibility for inclusion were conducted by independent researchers. Outcomes were prespecified and were informed by clinical experts and patient involvement. Data extraction and quality appraisal were conducted and results were synthesised narratively. We also developed a whole-disease economic model for Lynch syndrome using discrete event simulation methodology, including natural history components for colorectal, endometrial and ovarian cancer, and we used this model to conduct a cost–utility analysis of gynaecological risk management strategies, including surveillance, risk-reducing surgery and doing nothing.
Results
We found 30 studies in the review of clinical effectiveness, of which 20 were non-comparative (single-arm) studies. There were no high-quality studies providing precise outcome estimates at low risk of bias. There is some evidence that mortality rate is higher for surveillance than for risk-reducing surgery but mortality is also higher for no surveillance than for surveillance. Some asymptomatic cancers were detected through surveillance but some cancers were also missed. There was a wide range of pain experiences, including some individuals feeling no pain and some feeling severe pain. The use of pain relief (e.g. ibuprofen) was common, and some women underwent general anaesthetic for surveillance. Existing economic evaluations clearly found that risk-reducing surgery leads to the best lifetime health (measured using quality-adjusted life-years) and is cost-effective, while surveillance is not cost-effective in comparison. Our economic evaluation found that a strategy of surveillance alone or offering surveillance and risk-reducing surgery was cost-effective, except for path_PMS2 Lynch syndrome. Offering only risk-reducing surgery was less effective than offering surveillance with or without surgery.
Limitations
Firm conclusions about clinical effectiveness could not be reached because of the lack of high-quality research. We did not assume that women would immediately take up risk-reducing surgery if offered, and it is possible that risk-reducing surgery would be more effective and cost-effective if it was taken up when offered.
Conclusions
There is insufficient evidence to recommend for or against gynaecological cancer surveillance in Lynch syndrome on clinical grounds, but modelling suggests that surveillance could be cost-effective. Further research is needed but it must be rigorously designed and well reported to be of benefit. Study registration This study is registered as PROSPERO CRD42020171098. Funding This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR129713) and is published in full in Health Technology Assessment ; Vol. 28, No. 41. See the NIHR Funding and Awards website for further award information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Economics Group, University of Exeter, Exeter, UK.
- Peninsula Technology Assessment Group, University of Exeter, Exeter, UK.
- Exeter Policy Research Programme Evidence Review Facility, University of Exeter, Exeter, UK.
- NIHR Collaborations for Leadership in Applied Health Research and Care South West Peninsula, University of Exeter, Exeter, UK.
- Lynch Syndrome, Exeter, UK.
- Division of Cancer Sciences, School of Medical Sciences, University of Manchester, Manchester, UK.
ORCID-Profile: Tristan M Snowsill, Helen Coelho, Nia G Morrish, Simon Briscoe, Kate Boddy, Emma J Crosbie, Neil Aj Ryan, Fiona Lalloo, Claire T Hulme
Förderung
- Health Technology Assessment programme
Zitieren
APA
Snowsill, T. M., Coelho, H., Morrish, N. G., Briscoe, S., Boddy, K., Smith, T., Crosbie, E. J., Ryan, N. A., Lalloo, F., & Hulme, C. T. (2024). Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation. Health Technology Assessment, 1-228. https://doi.org/10.3310/vbxx6307
Vancouver
Snowsill TM, Coelho H, Morrish NG, Briscoe S, Boddy K, Smith T, et al. Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation. Health Technology Assessment. 2024:1-228. doi:10.3310/vbxx6307
BibTeX
@article{Snowsill2024,
author = {Snowsill, Tristan M and Coelho, Helen and Morrish, Nia G and Briscoe, Simon and Boddy, Kate and Smith, Tracy and Crosbie, Emma J and Ryan, Neil Aj and Lalloo, Fiona and Hulme, Claire T},
title = {Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation},
journal = {Health Technology Assessment},
year = {2024},
pages = {1--228},
doi = {10.3310/vbxx6307}
}
EUVIMED